Merck
MRK
1,926 hedge funds and large institutions have $130B invested in Merck in 2017 Q2 according to their latest regulatory filings, with 84 funds opening new positions, 796 increasing their positions, 779 reducing their positions, and 79 closing their positions.
51% more call options, than puts
Call options by funds: $1.77B | Put options by funds: $1.17B
6% more first-time investments, than exits
New positions opened: 84 | Existing positions closed: 79
2% more repeat investments, than reductions
Existing positions increased: 796 | Existing positions reduced: 779
1% more funds holding in top 10
Funds holding in top 10: 137 → 138 (+1)
0% more capital invested
Capital invested by funds: $130B → $130B (+$148M)
0.31% less ownership
Funds ownership: 77.91% → 77.61% (-0.31%)
1% less funds holding
Funds holding: 1,942 → 1,926 (-16)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$438M |
| 2 |
Nordea Investment Management
Stockholm,
Sweden
|
+$334M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$211M |
| 4 |
D.E. Shaw & Co
New York
|
+$190M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$180M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$735M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$576M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$231M |
| 4 |
Renaissance Technologies
New York
|
-$177M |
| 5 |
Bank of New York Mellon
New York
|
-$169M |
MRK Hedge Fund Activity: Q2 2017 in Review
1,926 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2017, worth a combined $130B — up 0.11% from $130B a quarter earlier.
Buyers outnumbered sellers: 84 funds opened new MRK positions and 79 closed out — a net gain of 5 holders — while 796 added to existing stakes and 779 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $438M. The largest seller was Capital World Investors, cutting an estimated $735M.
- 1,926 institutional investors held Merck (MRK) as of Q2 2017, down from 1,942 in Q1 2017.
- Funds reported $130B of Merck stock for Q2 2017, up 0.11% quarter-over-quarter.
- 84 funds opened new Merck positions in Q2 2017 and 79 closed out, a net change of +5 holders.
- The largest Merck buyer in Q2 2017 was T. Rowe Price Associates, an estimated $438M added.
- The largest Merck seller in Q2 2017 was Capital World Investors, an estimated $735M sold.
Based on aggregated 13F filings for Q2 2017.